Epilepsy Market Analysis

Diagnosis & Treatment (Imaging Devices, Blood Tests, Anti-Epileptic Drugs)

The global epilepsy market is segmented and analyzed for demand and supply by diagnosis & treatment into imaging devices, blood tests, anti-epileptic drugs, and others. Out of these, the imaging devices segment is attributed to holding the largest share of the market during the forecast period. The major factor attributed to segment growth is the increasing diagnostic imaging services across the globe and high investments made in the medical devices sector. As of 2022, the total worth of diagnostic imaging devices was estimated to be approximately USD 45 billion globally. Furthermore, the increasing advantages of imaging devices to detect and diagnose epilepsy are also estimated to bring lucrative growth opportunities for segment growth.

End-user (Hospitals, Clinics, Ambulatory Surgical Centers, Diagnostic Centers)

The global epilepsy market is also segmented and analyzed for demand and supply by end-user into hospitals, clinics, ambulatory surgical centers, diagnostic centers, and others. Out of these, the hospitals segment is projected to hold a significant share during the analysis period with a notable revenue generation. Effective treatment of neurological disorders and other chronic diseases is often conducted in hospitals with the availability of specialized doctors and advanced medical equipment. In addition, it’s easier and more convenient for the diagnosis and treatment processes of epilepsy. Also, the increased inflow and outflow of patients in the hospitals is another factor for the expansion of the segment size in the upcoming years.

Our in-depth analysis of the global market includes the following segments: